Validity of DNA-methylation marker PITX2 to predict risk of recurrence in lymph node-negative hormone receptor-positive breast cancer patients: a transfer study

Markert-Hahn, C. and Jaeger, S. and Dessauer, A. and Gehrke, R. and Krause, F. and Vogel-Ziebolz, S. and Schwope, I. and Hartmann, O. and Lesche, R. and Nimmrich, I. and Maier, S. and Harbeck, N. and Mueller, V. and Ross, J. S. and Gruetzmann, R. and Kristiansen, G. and Margossian, A. and Hartmann, A. and Golouh, R. and Paradiso, A. (2005) Validity of DNA-methylation marker PITX2 to predict risk of recurrence in lymph node-negative hormone receptor-positive breast cancer patients: a transfer study. In: 28th Annual San Antonio Breast Cancer Symposium, December 08 - 11, 2005, San Antonio, Texas.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Poster)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Depositing User: Petra Gürster
Date Deposited: 17 Mar 2022 08:56
Last Modified: 17 Mar 2022 08:56
URI: https://pred.uni-regensburg.de/id/eprint/36643

Actions (login required)

View Item View Item